Literature DB >> 20381459

MicroRNA-650 targets ING4 to promote gastric cancer tumorigenicity.

XueLi Zhang1, WeiYing Zhu, JiFa Zhang, ShouJun Huo, LianMing Zhou, Zhen Gu, Min Zhang.   

Abstract

MicroRNAs (miRNAs) are non-coding RNAs that regulate the expression of target mRNAs. Altered expression of specific miRNAs in human gastric cancer progression has been reported; however, the role of miR-650 in gastric cancer is poorly understood. In this study, we show that miR-650 is involved in lymphatic and distant metastasis in human gastric cancer, and we find that ectopic expression of miR-650 promotes tumorigenesis and proliferation of gastric cancer cells. A luciferase reporter assay demonstrates that Inhibitor of Growth 4 (ING4) is a direct target of miR-650. Collectively, our study demonstrates that over-expression of miR-650 in gastric cancer may promote proliferation and growth of cancer cells, at least partially through directly targeting ING4. These findings help clarify the molecular mechanisms involved in gastric carcinogenesis and indicate that miR-650 modulation may be a bona fide miRNA-based treatment of gastric cancer.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20381459     DOI: 10.1016/j.bbrc.2010.04.005

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  46 in total

1.  Role of extracellular vesicles in stem cell biology.

Authors:  Stefania Bruno; Giulia Chiabotto; Enrica Favaro; Maria Chiara Deregibus; Giovanni Camussi
Journal:  Am J Physiol Cell Physiol       Date:  2019-05-15       Impact factor: 4.249

2.  miR-650 promotes motility of anaplastic thyroid cancer cells by targeting PPP2CA.

Authors:  Francesca Maria Orlandella; Raffaela Mariarosaria Mariniello; Paola Lucia Chiara Iervolino; Esther Imperlini; Annalisa Mandola; Anna Verde; Anna Elisa De Stefano; Katia Pane; Monica Franzese; Silvia Esposito; Fulvio Basolo; Stefania Orrù; Giuliana Salvatore
Journal:  Endocrine       Date:  2019-03-29       Impact factor: 3.633

Review 3.  MicroRNAs in tumorigenesis, metastasis, diagnosis and prognosis of gastric cancer.

Authors:  C Jiang; X Chen; M Alattar; J Wei; H Liu
Journal:  Cancer Gene Ther       Date:  2015-05-22       Impact factor: 5.987

Review 4.  MicroRNA and signaling pathways in gastric cancer.

Authors:  Z Zhang; Z Li; Y Li; A Zang
Journal:  Cancer Gene Ther       Date:  2014-07-25       Impact factor: 5.987

5.  Essential role of microRNA-650 in the regulation of B-cell CLL/lymphoma 11B gene expression following transplantation: A novel mechanism behind the acute rejection of renal allografts.

Authors:  Peng Jin; Hongxi Chen; Jinliang Xie; Cheng Zhou; Xiangrong Zhu
Journal:  Int J Mol Med       Date:  2017-10-17       Impact factor: 4.101

6.  MicroRNA-650 in a copy number-variable region regulates the production of interleukin 6 in human osteosarcoma cells.

Authors:  Jun Ho Yun; Sanghoon Moon; Heun-Sik Lee; Mi Yeong Hwang; Yeon-Jung Kim; Ho-Yeong Yu; Youngsoo Kim; Bok-Ghee Han; Bong-Jo Kim; Jeong-Min Kim
Journal:  Oncol Lett       Date:  2015-08-07       Impact factor: 2.967

7.  MiR-330-3p inhibits gastric cancer progression through targeting MSI1.

Authors:  Aoran Guan; Hui Wang; Xun Li; Hui Xie; Ruotian Wang; Yankun Zhu; Ruhong Li
Journal:  Am J Transl Res       Date:  2016-11-15       Impact factor: 4.060

Review 8.  Biomarkers of Helicobacter pylori-associated gastric cancer.

Authors:  Cara L Cooke; Javier Torres; Jay V Solnick
Journal:  Gut Microbes       Date:  2013-07-12

Review 9.  Novel hepatocellular carcinoma molecules with prognostic and therapeutic potentials.

Authors:  Bruna Scaggiante; Maryam Kazemi; Gabriele Pozzato; Barbara Dapas; Rosella Farra; Mario Grassi; Fabrizio Zanconati; Gabriele Grassi
Journal:  World J Gastroenterol       Date:  2014-02-07       Impact factor: 5.742

Review 10.  Clinical application of microRNA in gastric cancer in Eastern Asian area.

Authors:  Ming Gao; Hao Yin; Zhe-Wei Fei
Journal:  World J Gastroenterol       Date:  2013-04-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.